tiprankstipranks
Trending News
More News >
Leap Therapeutics Inc (LPTX)
NASDAQ:LPTX
US Market

Leap Therapeutics (LPTX) Income Statement

Compare
898 Followers

Leap Therapeutics Income Statement

Last quarter (Q4 2024), Leap Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Leap Therapeutics's net income was $-15.43M. See Leap Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 1.50M$ 1.50M
Gross Profit
$ 0.00$ -427.00K$ -415.00K$ 1.50M$ 1.50M
Operating Expenses
$ 70.06M$ 86.61M$ 54.71M$ 41.70M$ 29.81M
Depreciation and Amortization
$ 0.00$ 427.00K$ 415.00K$ 556.00K$ 668.00K
EBITDA
$ -70.06M$ -80.99M$ -53.98M$ -40.01M$ -26.81M
Operating Income
$ -70.06M$ -87.04M$ -56.76M$ -41.43M$ -28.54M
Other Income/Expenses
$ 3.09M$ 5.63M$ 2.31M$ 815.00K$ 1.02M
Pretax Income
$ -66.97M$ -81.41M$ -54.45M$ -40.61M$ -27.52M
Net Income
$ -67.79M$ -81.41M$ -54.60M$ -40.59M$ -27.51M
Per Share Metrics
Basic EPS
$ -1.81$ -3.98$ -4.82$ -4.73$ -4.64
Diluted EPS
$ -1.81$ -3.98$ -4.82$ -4.73$ -4.64
Weighted Average Shares Outstanding
37.55M 20.45M 11.32M 8.58M 5.93M
Weighted Average Shares Outstanding (Diluted)
37.55M 20.45M 11.32M 8.58M 5.93M
Currency in USD

Leap Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis